Oxy Pharm Private Limited
About Oxy Pharm Private Limited
Data last updated:
Oxy Pharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 October 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1980PTC023348. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sonal Rakesh Shah and Gautam Vijay Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No – 2 Atal Murbad Thane Forest Fata, Mumbai, Maharashtra, India – 421401.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.53 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹1,169 (net margin -0.8%) and EBITDA of ₹37,756 (EBITDA margin 24.8%). Revenue has declined at a compounded annual rate (CAGR) of 41% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Oxy Pharm Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressH No – 2 Atal Murbad Thane Forest Fata, Mumbai, Maharashtra, India – 421401
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oxy Pharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxy Pharm is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Oxy Pharm Private Limited, buy the company report.
Financials of Oxy Pharm Private Limited
FY 2025 filings availableOxy Pharm Private Limited reported revenue of ₹1.53 Lakh (up 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 41%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37,756 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,169 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.8% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oxy Pharm Private Limited, buy the company report.
Board of directors of Oxy Pharm Private Limited
Oxy Pharm has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonal Rakesh Shah | Director | 17 May 2019 | 7 Years 5 Months | Current |
| Gautam Vijay Shah | Director | 17 Feb 2022 | 4 Years 8 Months | Current |
Auditor
Oxy Pharm Private Limited is audited by KANHAIYA GAUTAM & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KANHAIYA GAUTAM & ASSOCIATES | FY 2020 | 142368W |
Shareholding
The shareholding of Oxy Pharm Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Oxy Pharm Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oxy Pharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxy Pharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oxy Pharm has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Oxy Pharm Private Limited, buy the company report.
Recent activity
Oxy Pharm Private Limited has 11 board changes on record since 2008: 2 appointments and 9 cessations. The latest: Gautam Vijay Shah was appointed as Director on 17 Feb 2022.
2 earlier events are in the company report.
Frequently asked questions
Oxy Pharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 October 1980 (46+ years old) and is registered under CIN U24230MH1980PTC023348.
Oxy Pharm has 2 current directors:
- Sonal Rakesh Shah - Director
- Gautam Vijay Shah - Director
The latest financial statements of Oxy Pharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Oxy Pharm has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Oxy Pharm is U24230MH1980PTC023348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxy Pharm was incorporated on 27 October 1980, making it 46+ years old. It is registered with the Registrar of Companies, Mumbai.
Gautam Vijay Shah was appointed as Director on 17 Feb 2022. Siddhant Sunil Seksaria ceased to be Director on 31 Oct 2019. Snigdha Sunil Seksaria ceased to be Director on 31 Oct 2019. Oxy Pharm has 11 board changes on record in total.
The registered office of Oxy Pharm is at H No – 2 Atal Murbad Thane Forest Fata, Mumbai, Maharashtra, India – 421401.
Oxy Pharm operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Oxy Pharm is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.